Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine-glycine-aspartic acid (RGD)- and non-RGD-binding integrins.
about
Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatmentRole of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression.Gene therapy works in animal models of rheumatoid arthritis...so what!Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus.Gene therapy of the rheumatic diseases: 1998 to 2008.Integrin targeted drug and gene delivery.Human ESC vs. iPSC-pros and cons.Drug delivery technologies for autoimmune disease.Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides.PUMA gene delivery to synoviocytes reduces inflammation and degeneration of arthritic joints.Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression.Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
P2860
Q28248671-F41EE8D1-2119-4AD0-A137-83A2BDF4CB1EQ33728533-9563601B-46CA-49F0-B4D4-190B186FC3B6Q36594242-C34FF8FC-DDB9-46FE-BF5B-47FA5386F3A4Q37204634-DFA54208-D4AB-41CA-9B6D-8F2B8174EF7BQ37207021-A2037D75-BE90-4327-B10B-D68AA1B69EBAQ37679945-86449729-A850-45E5-A072-ECBDD1958406Q37766133-ADAD11E0-D622-4A16-A79A-A2997C20ADA3Q37801381-30EBE205-65F0-4C72-8512-F1B53E3F4401Q39171777-83836F33-9FAE-4E7C-8CA9-2658FD0560C2Q40106950-D95D46CA-93C9-4A49-9F77-0B581ADBBCF1Q41876336-E0AA3EBF-289E-4326-AF0A-798CAEEB8329Q54369171-8C7291D1-2B93-496A-BC3A-BE735BEF8C08
P2860
Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine-glycine-aspartic acid (RGD)- and non-RGD-binding integrins.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Enhancement of adenovirus-medi ...... and non-RGD-binding integrins.
@en
Enhancement of adenovirus-medi ...... arginine-glycine-aspartic acid
@nl
type
label
Enhancement of adenovirus-medi ...... and non-RGD-binding integrins.
@en
Enhancement of adenovirus-medi ...... arginine-glycine-aspartic acid
@nl
prefLabel
Enhancement of adenovirus-medi ...... and non-RGD-binding integrins.
@en
Enhancement of adenovirus-medi ...... arginine-glycine-aspartic acid
@nl
P2093
P1476
Enhancement of adenovirus-medi ...... and non-RGD-binding integrins.
@en
P2093
Fons van de Loo
Laure Franqueville
Leif Lindholm
Myew-Ling Toh
Pierre Boulanger
Pierre Miossec
Saw-See Hong
Wim van den Berg
P304
P356
10.4049/JIMMUNOL.175.11.7687
P407
P577
2005-12-01T00:00:00Z